On pharmacogenomics and cost-effectiveness analysis at the individual level

Temperature exposure and fatal overdose.

Drug and alcohol dependence·2026

Cost-effectiveness of community-based interventions for reducing opioid overdose and non-overdose deaths: simulation modeling of HEALing Communities Study.

Lancet regional health. Americas·2026

Cascade of Care for Opioid Use Disorder Among Medicaid Beneficiaries.

JAMA network open·2026

Impact of enhanced practices on opioid overdose deaths: A community-based modeling approach.

Addiction (Abingdon, England)·2026

Estimating community-level prevalence of opioid use disorder: Extrapolating from Medicaid claims data and other publicly available data sources in Ohio, USA.

Addiction (Abingdon, England)·2025

The impact of the communities that HEAL intervention on the provision of jail-based medication for opioid use disorder & linkage programs at release: Results from a randomized, wait-list controlled trial.

Journal of substance use and addiction treatment·2025

Missing Data in Trial-Based Cost-Effectiveness Analysis: The Journey Continues.

PharmacoEconomics·2026

External Validation of SELECT Trial-Derived Cardiovascular Risk Equations in a UK Population with Overweight or Obesity and Established Cardiovascular Disease Without Diabetes.

PharmacoEconomics·2026

A Machine Learning and Large Language Model Tool for Systematic Literature Reviews of Health Economic Evidence: A Validation Study.

PharmacoEconomics·2026

A Cost-Effectiveness Model of Semaglutide 2.4 mg, Resmetirom 80 mg, and Resmetirom 100 mg Versus Standard of Care for the Treatment of Metabolic Dysfunction-Associated Steatohepatitis in the United States.

PharmacoEconomics·2026

Uncertainty in Economic Evaluation: A Pragmatic Guide for Health Technology Assessment (HTA) Agencies in Resource-Constrained Settings.

PharmacoEconomics·2026

Cost-Effectiveness and Budget Impact of Lung Cancer Screening: A Systematic Review.

PharmacoEconomics·2026

Association of sleep duration and hypertension in Older Adults: a cross-sectional study.

Blood pressure·2026

Analysis of the effects of heat-not-burn tobacco product use on cardiorespiratory symptoms in adults.

Medicinski glasnik : official publication of the Medical Association of Zenica-Doboj Canton, Bosnia and Herzegovina·2026

Reframing analytical treatment interruption through participants' and decliners' eyes: insights from an HIV remission trial.

AIDS (London, England)·2026

Prevalence, Predictors and Sexual Health Correlates of Heavy Episodic Drinking Among Females of Reproductive Age in Ghana.

Public health challenges·2026

Effects of direct tracheostomy on ventilator weaning in patients intubated for Guillain-Barré syndrome.

Annals of intensive care·2026

Sleep disturbance partially mediates the association between depression and epilepsy: data from NHANES 2013-2020.

Epilepsy & behavior reports·2026

Related Experiment Videos

On pharmacogenomics and cost-effectiveness analysis at the individual level

Related Concept Videos

Temperature exposure and fatal overdose.

Cost-effectiveness of community-based interventions for reducing opioid overdose and non-overdose deaths: simulation modeling of HEALing Communities Study.

Cascade of Care for Opioid Use Disorder Among Medicaid Beneficiaries.

Impact of enhanced practices on opioid overdose deaths: A community-based modeling approach.

Estimating community-level prevalence of opioid use disorder: Extrapolating from Medicaid claims data and other publicly available data sources in Ohio, USA.

The impact of the communities that HEAL intervention on the provision of jail-based medication for opioid use disorder & linkage programs at release: Results from a randomized, wait-list controlled trial.

Missing Data in Trial-Based Cost-Effectiveness Analysis: The Journey Continues.

External Validation of SELECT Trial-Derived Cardiovascular Risk Equations in a UK Population with Overweight or Obesity and Established Cardiovascular Disease Without Diabetes.

A Machine Learning and Large Language Model Tool for Systematic Literature Reviews of Health Economic Evidence: A Validation Study.

A Cost-Effectiveness Model of Semaglutide 2.4 mg, Resmetirom 80 mg, and Resmetirom 100 mg Versus Standard of Care for the Treatment of Metabolic Dysfunction-Associated Steatohepatitis in the United States.

Uncertainty in Economic Evaluation: A Pragmatic Guide for Health Technology Assessment (HTA) Agencies in Resource-Constrained Settings.

Cost-Effectiveness and Budget Impact of Lung Cancer Screening: A Systematic Review.

Association of sleep duration and hypertension in Older Adults: a cross-sectional study.

Analysis of the effects of heat-not-burn tobacco product use on cardiorespiratory symptoms in adults.

Reframing analytical treatment interruption through participants' and decliners' eyes: insights from an HIV remission trial.

Prevalence, Predictors and Sexual Health Correlates of Heavy Episodic Drinking Among Females of Reproductive Age in Ghana.

Effects of direct tracheostomy on ventilator weaning in patients intubated for Guillain-Barré syndrome.

Sleep disturbance partially mediates the association between depression and epilepsy: data from NHANES 2013-2020.

Related Experiment Videos

On pharmacogenomics and cost-effectiveness analysis at the individual level

Related Concept Videos

Related Articles